Is Eiko Lifesciences a good stock to invest in?

Eiko Lifesciences can be analyzed on the following key metrics - TTM P/E: 32.52 Sector P/E: 0 Dividend Yield: 0% D/E ratio: -

Eiko Lifesciences Share Price

Sector: Chemical Manufacturing

Powered by

50.74 +0.61 (1.22%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 48.55

Today’s High 50.90

52 Week Low 42.00

52 Week High 74.88

Key Metrics

Market Cap (In Cr) 69.62
Beta -0.35
Div. Yield (%) 0
P/B 1.23
TTM P/E 32.52
Sector P/E 0
D/E 0
Open Price 50
Prev Close 50.13

View All Metrics

Eiko Lifesciences Analysis

Price Analysis

1 Week

1.85%
3 Months

-3.19%
6 Month

-17.95%
YTD

-19.25%
1 Year

3.6%

Risk Meter

50% Low risk
50% Moderate risk
50% Balanced Risk
50% High risk
50% Extreme risk

Eiko Lifesciences News

Q4 results today, on May 14: Eicher Motors, Tata Power, Lupin, Apollo Tyres, Muthoot Finance, Jubilant Foodworks, Shree Cements, Sagility, and Berger Paints India are among 116 companies that will release their Q4FY25 earnings. (Image: Pixabay)

Premium

Q4 results today: Tata Power, Eicher Motors, Lupin, Shree Cements on May 14

1 min read . 14 May 2025

The fourth quarter earnings season for this fiscal year began in the second week of April and is still ongoing. Over 500 companies are scheduled to announce their fourth quarter results in this week. (Mint)

Premium

Q4 results today: Varun Beverages, Zomato & Sanofi to report earnings on May 13

1 min read . 13 May 2024

View More News

Eiko Lifesciences Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
37.66

Selling/ General/ Admin Expenses Total
0.37

Depreciation/ Amortization
0.74

Other Operating Expenses Total
1.88

Total Operating Expense
35.3

Operating Income
2.36

Net Income Before Taxes
3.06

Net Income
2.32

Diluted Normalized EPS
1.44

Period
2024

Total Revenue
27.93

Selling/ General/ Admin Expenses Total
0.22

Depreciation/ Amortization
0.66

Other Operating Expenses Total
0.68

Total Operating Expense
26.98

Operating Income
0.95

Net Income Before Taxes
0.98

Net Income
0.75

Diluted Normalized EPS
0.73

Period
2023

Total Revenue
18.32

Selling/ General/ Admin Expenses Total
0.29

Depreciation/ Amortization
0.63

Other Operating Expenses Total
0.99

Total Operating Expense
18

Operating Income
0.32

Net Income Before Taxes
1.03

Net Income
0.77

Diluted Normalized EPS
0.8

Period
2022

Total Revenue
25.41

Selling/ General/ Admin Expenses Total
0.28

Depreciation/ Amortization
0.56

Other Operating Expenses Total
1.26

Total Operating Expense
24.68

Operating Income
0.73

Net Income Before Taxes
0.94

Net Income
0.71

Diluted Normalized EPS
0.78

Period
2021

Total Revenue
11.99

Selling/ General/ Admin Expenses Total
0.12

Depreciation/ Amortization
0.06

Other Operating Expenses Total
0.74

Total Operating Expense
11.53

Operating Income
0.46

Net Income Before Taxes
0.83

Net Income
0.61

Diluted Normalized EPS
1.39

Period
2020

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.07

Depreciation/ Amortization
0.06

Other Operating Expenses Total
0.1

Total Operating Expense
0.23

Operating Income
-0.23

Net Income Before Taxes
0.13

Net Income
0.13

Diluted Normalized EPS
0.29

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Eiko Lifesciences Technical

Moving Average SMA

5 Day49.23
10 Day49.78
20 Day50

50 Day50.68
100 Day51.72
300 Day56.14

Eiko Lifesciences Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Kemistar Corporation
76.5
1.54
2.05
116.45
37
82.26

Mysore Petro Chemicals
125
0.45
0.36
261.9
117.45
82.3

Eiko Lifesciences
50.74
0.61
1.22
74.88
42
69.62

Shree Hari Chemicals Export
138.75
4.6
3.43
173.9
70.01
61.7

Shreyas Intermediates
9.6
-0.12
-1.23
20.2
7.79
68.02

Eiko Lifesciences Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

14-May-25
Audited Results

12-Feb-25
Quarterly Results

25-Nov-24
Rights issue of Equity Shares

19-Oct-24
Quarterly Results

13-Aug-24
Quarterly Results

13-May-24
Audited Results

08-Feb-24
Quarterly Results

14-Dec-23
Others

08-Nov-23
Quarterly Results

11-Jul-23
Quarterly Results

Meeting Date
Announced on
Purpose

28-Sept-24
16-Sept-24
AGM

23-Sept-23
30-Aug-23
AGM

06-Mar-23
31-Jan-23
POM

31-Mar-21
10-Mar-21
EGM

-
14-Dec-23
Others

Announced on
Record Date
Ex-Rights Date
Ratio
FV
Premium
Description

31-Jan-23
07-Jul-23
07-Jul-23
2:3
10
35
Rights issue of equity shares of Rs. 10/- in the ratio of 2:3 @ premium of Rs. 35/-.

View All

Company Profile

ABOUT Eiko Lifesciences

Industry Chemical Manufacturing
ISIN INE666Q01016
BSE Code 540204

Eiko LifeSciences Limited is an India-based company engaged in manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and fine chemicals. It operates in the Specialty & Fine Chemicals segment. It offers products in Specialty Chemicals and Intermediates, Application Programming Interfaces (APIs), Agrochemical Intermediates, Flavor & Fragrances, and Cosmetic Emollients. Specialty Chemicals and Intermediates include Lasamide, Trichloro Salicylic acid, Chloroacetyl Xylidide and Thiodipropionic acid. Agrochemical Intermediates include 5-chloro-8-hydroxyquinoline. Cosmetic Emollients include Isopropyl Oleate, Isopropyl Laurate, Isopropyl Palmitate, Isopropyl Myristate, Methyl Myristate, Butyl Oleate, Butyl Laurate, and Methyl Myristate, among others. APIs include Topiramate Indian Pharmacopoeia (IP), (United States Pharmacopeia) USP/ European Pharmacopeia (EP), and Glucosamine hydrochloride (HCL)/Sodium/Potassium USP/EP, among others.

MANAGEMENT

Jaid Kojar Chief Financial Officer
Chintan Doshi Compliance Officer, Company Secretary
Umesh More Whole Time Director

EIKO LIFESCIENCES SUMMARY

Eiko Lifesciences is trading 1.22% upper at Rs 50.74 as compared to its last closing price. Eiko Lifesciences has been trading in the price range of 50.90 & 48.55. Eiko Lifesciences has given -19.25% in this year & 1.85% in the last 5 days.

Eiko Lifesciences has TTM P/E ratio 32.52.

The company posted a net profit of 1.24 Crores in its last quarter.

Listed peers of Eiko Lifesciences include Kemistar Corporation (2.05%), Mysore Petro Chemicals (0.36%), Eiko Lifesciences (1.22%) etc.

Eiko Lifesciences has a 36.23% promoter holding & 63.77% public holding.

FAQs about Eiko Lifesciences

Eiko Lifesciences is trading at 50.74 as on 27 Jun, 2025 3:29:13 PM. This is 1.22% upper as compared to its previous closing price of 50.13

The market capitalization of Eiko Lifesciences is 69.62 Cr as on 27 Jun, 2025 3:29:13 PM.

The 52 wk high for Eiko Lifesciences is 74.88 whereas the 52 wk low is 42.00

Eiko Lifesciences can be analyzed on the following key metrics -

TTM P/E: 32.52
Sector P/E: 0
Dividend Yield: 0%
D/E ratio: -

Eiko Lifesciences reported a net profit of 2.32 Cr in 2025.

Eiko Lifesciences Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Eiko Lifesciences Share Price

Price Range

Key Metrics

Eiko Lifesciences Analysis

Eiko Lifesciences News

Q4 results today: Tata Power, Eicher Motors, Lupin, Shree Cements on May 14

Q4 results today: Varun Beverages, Zomato & Sanofi to report earnings on May 13

Eiko Lifesciences Financials

Forecast

Forecast

Forecast

Eiko Lifesciences Technical

Eiko Lifesciences Peers

Eiko Lifesciences Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Eiko Lifesciences

MANAGEMENT

EIKO LIFESCIENCES SUMMARY

FAQs about Eiko Lifesciences

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue